1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow PF06700841: new trials by email Literature Review of PF06700841 trials Research Report on PF06700841
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects PF-06651600, placebo, PF06700841 - Active Non-segmental Vitiligo | Phase 2 | Completed | Pfizer | 366 | 2018-11-26 | 2022-03-25 |
Pfizer (1)
Australia (1) · Belgium (1) · Canada (1) · Germany (1) · Italy (1) · Japan (1) · South Korea (1) · Spain (1) · Taiwan (1) · United States (1)
PMID 36370907, PMID 37777018, PMID 37917289, PMID 39023568, PMID 42081176
2018 (1)